Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search:
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Showing
1
-
20
of
152
Search:
''
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian drug expert committee recommendation: Doravirine (Pifeltro -- Merck Canada Inc.) : indication: in combination with other antiretroviral medicinal products, for the t...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Obeticholic acid (Ocaliva--Intercept Pharmaceuticals Canada) : indication : primary biliary cholangitis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
3
CADTH Canadian Drug Expert Committee final recommendation: Tesamorelin (Egrifta -- Theratechnologies Inc.) indication : HIV-associated lipohypertherapy
Published 2016
Canadian Agency for Drugs and Technologies in Health
Read Now
4
CADTH Canadian Drug Expert Committee recommendation (final): Sebelipase alfa (Kanuma -- Alexion Pharmaceuticals, Inc.) indication : lysosomal acid lipase deficiency
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
5
CADTH Canadian Drug Expert Committee final recommendation: Ticagrelor (Brilinta -- AstraZeneca Canada Inc.) indication : secondary prevention of atherothrombotic events
Published 2016
Canadian Agency for Drugs and Technologies in Health
Read Now
6
CADTH Canadian Drug Expert Committee recommendation (final): Letermovir (Prevymis -- Merck Canada Inc.) indication : cytomegalovirus infection, prophylaxis
Published 2018
CADTH
Read Now
7
CADTH Canadian Drug Expert Committee recommendation: Dexamethasone (Ozurdex -- Allergan Canada Inc.) indication: for the treatment of adult patients with diabetic macular edema who...
Published 2018
CADTH
Read Now
8
CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis
Published 2018
CADTH
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (nitisinone tablets -- Cycle Pharmaceuticals Ltd.) : indication : the treatment of adult and pediatric patients with...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Ozenoxacin 1% cream (Ozanex -- Ferrer Internacional, S.A.) : indication: the topical treatment of impetigo in patients aged two...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
11
CADTH Canadian Drug Expert Committee recommendation: Cladribine (Mavenclad -- EMD Serono) : indication: relapsing-remitting multiple sclerosis
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
12
CADTH Canadian drug expert committee recommendation: Doravirine/Lamivudine/Tenofovir disoproxil fumarate (Delstrigo -- Merck Canada Inc.) : indication: as a complete regimen for th...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
13
CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthri...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
14
CADTH Canadian drug expert committee recommendation: Cyclosporine 0.1% (Verkazia -- Santen Canada Inc.) : indication : treatment of severe vernal keratoconjunctivitis in children f...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
15
CADTH Canadian drug expert committee recommendation: Lanadelumab (Takhzyro -- shire pharma Canada ULC) : indication: for the routine prevention of attacks of hereditary angioedema...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
16
Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
17
Clinical review report: Lanadelumab (Takhzyro) (Shire pharma Canada ULC) : indication : for routine prevention of attacks of hereditary angioedema in adolescents and adults
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
18
Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
19
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...
Published 2019
CADTH
Read Now
20
CADTH Canadian Drug Expert Committee final recommendation: Edoxaban : Lixiana-Servier Canada Inc. : indication : venous thromboembolic events
Published 2017
Canadian Agency for Drugs and Technologies in Health
1
2
3
4
5
6
7
8
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
610 - Medicine & health
144
330 - Economics
68
140 - Specific philosophical schools
19
700 - The arts; fine & decorative arts
14
580 - Plants (Botany)
2
Language
English
152
Collection
National Center for Biotechnology Information
152
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&type=AllFields
Send by Email
×
Loading...